While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

The company will compete with a device Boston Scientific acquired for $850 million.

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

Many companies forecast specific tariff charges. Then the White House and China agreed to a 90-day pause in their trade ...

“For too long, Johnson & Johnson has used tying arrangements and other tactics to interfere with fair competition from ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Inside the evolving science of sterilization compatibility and why your next packaging decision might improve patient ...

Teal won FDA approval for a self-collection device after running a study at 16 sites in the U.S. Writing in the JAMA paper, ...

The White House will alert countries of their specific rates in the next two to three weeks, President Donald Trump said ...

The biotech, which has for years invested in genetics research, plans to acquire "substantially all" of testing firm ...

Witty’s departure was surprising, though it follows a sharp downturn in the healthcare juggernaut’s financial outlook. He is ...